Evaluating the Impact of Clinical Pharmacist-Developed Protocols in Chronic Disease Management: A Systematic Review of Patient Health Outcomes
Abstract
Purpose: The purpose of this study is to explain the impact of clinical pharmacist-developed protocols on improving disease control markers in chronic disease patients and the effectiveness of these protocols in increasing patient adherence to treatment plans and reducing healthcare.
Methods: Search for studies in databases like PubMed, Cochrane Library, Embase, and CINAHL using terms such as “pharmacist-developed protocols,” “clinical pharmacist chronic disease protocols,” “protocols in diabetes/hypertension management,” and “protocol outcomes in chronic disease.”
Conclusion: Improved CDM for a range of illnesses resulted from pharmacists' ability to influence clinical and humanistic outcomes in the FQHC when given prescription authority and collaborating with an interdisciplinary primary care team. To confirm these findings in different contexts, more research ought to be done.
Letters in High Energy Physics (LHEP) is an open access journal. The articles in LHEP are distributed according to the terms of the creative commons license CC-BY 4.0. Under the terms of this license, copyright is retained by the author while use, distribution and reproduction in any medium are permitted provided proper credit is given to original authors and sources.
Terms of Submission
By submitting an article for publication in LHEP, the submitting author asserts that:
1. The article presents original contributions by the author(s) which have not been published previously in a peer-reviewed medium and are not subject to copyright protection.
2. The co-authors of the article, if any, as well as any institution whose approval is required, agree to the publication of the article in LHEP.
